The Thrombosis And Hemostasis Biomarkers Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Thrombosis And Hemostasis Biomarkers Market?
The market size for thrombosis and hemostasis biomarkers has been on an upward trend over recent years. It is expected to rise from $4.8 billion in 2024 to $5.17 billion in 2025 with a Compound Annual Growth Rate (CAGR) of 7.8%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Thrombosis And Hemostasis Biomarkers Industry?
The Thrombosis And Hemostasis Biomarkers Global Market Report 2025 projects that by 2029, the market size will be $6.87 billion, expanding at a compound annual growth rate (CAGR) of 7.4%.
Download Your Free Sample of the 2025 Thrombosis And Hemostasis Biomarkers Market Report and Uncover Key Trends Now!
Global Market Segmentation: Identifying Major Thrombosis And Hemostasis Biomarkers Industry Segments
The thrombosis and hemostasis biomarkers market covered in this report is segmented –
1) By Product: Reagents And Consumables, Analyzers
2) By Test Type: D-Dimer, Anti-Thrombin III, Plasminogen, Soluble Fibrin, Factor VIII, Post-Thrombin (PT), Activated Partial Thromboplastin Time (APTT) Test, Other Test Types
3) By Application: Cardiovascular Disorders, Neurological Disorders, Oncology, Pregnancy-Related Disorders, Orthopedic Procedures
4) By End User: Hospitals, Diagnostics Laboratories, Pharmaceutical Companies, Academic Institutions, Home Healthcare Settings
What are the Key Growth Drivers Fueling the Thrombosis And Hemostasis Biomarkers Market?
The key drivers in the thrombosis and hemostasis biomarkers marketare:
• Higher incidence of stroke and ischemic conditions
• Increasing awareness of venous thromboembolism
• Rising prevalence of hemophilia and other bleeding disorders
• Growing population undergoing surgeries and increasing healthcare expenditure
Pre-order the 2025 Thrombosis And Hemostasis Biomarkers Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Thrombosis And Hemostasis Biomarkers Market?
The key trends in the thrombosis and hemostasis biomarkers market are:
• Innovations in biomarker detection techniques are shaping the thrombosis and hemostasis biomarkers market.
• Development of high-sensitivity assays for D-dimer and fibrinogen is an emerging trend.
• The emergence of point-of-care diagnostic devices is a significant factor in the market.
• The integration of AI in biomarker analysis and prediction and automation in laboratory diagnostics are upcoming trends in this sector.
Who Are the Top Competitors & Leading Players in the Thrombosis And Hemostasis Biomarkers Market?
Major companies in the thrombosis and hemostasis biomarkers market are:
• F. Hoffmann-La Roche Ltd.
• Thermo Fisher Scientific Inc.
• Abbott Laboratories
• Siemens Healthineers AG
• Becton, Dickinson and Company (BD)
• Mayo Clinic Laboratories
• bioMérieux S.A.
• Beckman Coulter Inc.
• QuidelOrtho Corporation
• Bio-Rad Laboratories Inc.
• Cincinnati Children's Hospital Medical Center
• ARUP Laboratories
• HORIBA Ltd.
• Werfen S.A.
• Pathkind Diagnostics Pvt. Ltd.
• Diagnostica Stago
• Agilus Diagnostics
• Helena Laboratories Corporations
• Cleveland Clinic Laboratories
• Diazyme Laboratories Inc.
• Biomedica Diagnostics Inc.
• Atlas Medical GmbH
Regional Dominance: Which Area Leads the Global Thrombosis And Hemostasis Biomarkers Market?
North America was the largest region in the thrombosis and hemostasis biomarkers market in 2024
